Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Monday, June 25, 2018 · 452,977,907 Articles · 3+ Million Readers

Prolor Biotech Raises $24.4 Million

March 21, 2010 (FinancialWire) — Prolor Biotech, Inc., (OTCBB: PBTH), a company developing next generation biobetter therapeutic proteins, said it has raised $24.4 million in a private placement of 10,382,975 shares of its common stock, par value $0.00001 per share, to accredited investors at a price of $2.35 per share.

The sale price represents a roughly 17% discount to the average closing price of the firm’s common stock for the 30-day period prior to closing.

Jefferies & Co. served as lead placement agent on the transaction.

Israel-based Prolor Biotech is a biopharmaceutical company applying various technologies, including its patented CTP technology, primarily to develop longer-acting, biobetter, proprietary versions of already approved therapeutic proteins.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Powered by EIN Presswire